PHOCABO (Cabozantinib) 20mg | Multi-Kinase Inhibitor | Pharma 2 Vientiane | GLT

PHOCABO is a generic cabozantinib produced by Pharma 2 Vientiane, the second state pharmaceutical factory of Laos. It supplies the 20 mg capsule in packs of 90, the lower of the two standard capsule strengths, at a cost well below the originator Cometriq. The facility has completed remediation and is in normal production, and GLT sources current batches.

Generic Information: PHOCABO (Cabozantinib)

Pharma 2 Vientiane (State Pharmaceutical Factory No. 2) is one of Laos's principal public-sector drug manufacturers, producing generic oncology medicines under GMP standards for the domestic market and export. PHOCABO is its cabozantinib line, named to signal the active molecule while remaining a distinct brand. It contains the same cabozantinib as the originator.

What Is PHOCABO (Cabozantinib) Used For?

PHOCABO treats advanced and metastatic cancers, including medullary thyroid cancer, renal cell carcinoma, hepatocellular carcinoma, differentiated thyroid cancer and neuroendocrine tumors. As a generic, it contains the same active ingredient (cabozantinib) as the originator brands Cometriq and Cabometyx.

How Does PHOCABO Work?

Cabozantinib is a multi-kinase inhibitor that blocks MET, VEGFR-2, RET, AXL, KIT and FLT-3. By inhibiting these receptor tyrosine kinases, it suppresses tumor growth, reduces the new blood-vessel formation that tumors depend on, and limits metastasis. PHOCABO reproduces this mechanism at a lower price.

Indications

• Progressive, metastatic medullary thyroid cancer
• Advanced renal cell carcinoma, including with a checkpoint inhibitor
• Hepatocellular carcinoma after sorafenib
• Differentiated thyroid cancer refractory to radioactive iodine
• Well-differentiated neuroendocrine tumors

Dosage & Administration

The 20 mg capsule in this listing is one of the two standard strengths used to make up the recommended daily dose, which varies by indication — 140 mg daily for medullary thyroid cancer and 60 mg daily for most other indications. Capsules are swallowed whole. Dose adjustment is directed by the physician.

Side Effects

Diarrhea, fatigue, nausea, decreased appetite, hand-foot skin reaction and high blood pressure are common. Serious risks include severe bleeding, gastrointestinal perforation, blood clots, heart problems and osteonecrosis of the jaw. Blood pressure and liver function are monitored during treatment.

Storage & Handling

Store at room temperature in the original packaging, protected from moisture and light, out of children's reach, and not past expiry.

Why Choose PHOCABO?

• Lower-cost generic — the same cabozantinib at a fraction of the originator price.
• Lao state manufacturer — Pharma 2 Vientiane with GMP production.
• Available supply — the plant is operating normally.

How to Order PHOCABO from GLT

1. Contact GLT via WhatsApp +86 15234153837 or email [email protected] with quantity and destination.
2. Receive a quotation and delivery estimate.
3. Pay through Hao Yi Lian / 好易联.
4. Goods ship with documentation and tracking.

A valid prescription may be requested before dispatch. Institutions and individual patients are served.

FAQ

1. Is PHOCABO still available?

Yes, the Lao Pharma 2 plant is in normal production and GLT supplies current batches.

2. Is PHOCABO a generic of Cometriq?

It is a generic cabozantinib containing the same active ingredient, made by a different manufacturer.

3. Do I need a prescription?

Yes, cabozantinib is prescription-only.